Lantheus
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
201 Burlington Rd, Bedford, Massachusett...Phone Number
(800) 362-2668Website
www.lantheus.comRevenue
$1.6 BillionStock Symbol
LNTHIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
2
2
2
1
1
About Lantheus
Lantheus is a healthcare technology company headquartered in Bedford, Massachusetts with additional offices in New Jersey, Canada, and Sweden. Founded in 1956, the company pioneers medical imaging technologies and provides innovative diagnostics, targeted therapeutics, and artificial intelligence solutions for healthcare. Lantheus specializes in developing software and health technologies that empower clinicians to effectively identify, treat, and monitor various diseases. The company maintains a diverse product portfolio focused on enhancing patient care through advanced medical imaging and diagnostic tools. As a publicly traded company since 2019, Lantheus continues to expand its global presence while maintaining its commitment to innovation in healthcare technology.Explore more
Lantheus Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lantheus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Lantheus recently announced quarterly report
Click to see if Lantheus had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Lantheus has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Lantheus launches new products
Check out if Lantheus is spiking on competitors!
Funding: Get notified immidiatlly once Lantheus has new funding data
Lantheus, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Lantheus
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Lantheus
Compare insights from companies similar to Lantheus, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Lantheus is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Lantheus is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lantheus.
Lantheus financials insights
Gather financial insights about Lantheus, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$65M
Lantheus Tech Stack
A closer look at the technologies used by Lantheus
See more technologies
Most Recent Scoops
Hiring Plans
Lantheus has more open roles in Human Resources than it has had at any time in the past 6 months. Technologies mentioned include: Ideal. Areas of expertise include: Self-Directed Learning, Educational Needs Assessment, Blended Learning, Adult Learning Principles, Curriculum Development, Capability Development, and Program Evaluation.
Hiring Plans
Open Position
Open Position
Open Position
Hiring Plans
Hiring Plans
Lantheus News & Media
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
BEDFORD, Mass., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced U.S. Food and Drug Administration (FDA) approval of TAUKLARIFY™ (florquinitau F 18 injection), also referred to as MK-6240, a radiodiagnostic agent indicated for positron emission tomography (PET) of the brain inLantheus Reports Second Quarter 2026 Financial Results
BEDFORD, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today reported financial results for its second quarter ended June 30, 2026.Shareholder Alert: Ademi LLP investigates whether Lantheus Holdings, Inc. is obtaining a Fair Price for Public Shareholders
MILWAUKEE, Aug. 3, 2026 /PRNewswire/ -- Ademi LLP is investigating Lantheus (NASDAQ: LNTH) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Curium. Click here to learn how to join our investigation and obtain additional...Curium Announces Definitive Agreement to Merge with Lantheus
BOSTON and BEDFORD, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Curium™, a leading, global radiopharmaceutical company with proven expertise in the development, manufacturing and supply of radiopharmaceuticals that improve the way cancer is diagnosed and treated, and Lantheus Holdings, Inc. (“Lantheus” or “Company”) (NASDAQ: LNTH), today announced that Curium US Holdings LLC (“Curium US”) and Lantheus have entered into a definitive agreement under which Lantheus, a leading radiopharmaceutical-focus
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lantheus
Sign Up For FreeTo access detailed company insights
Lantheus is a healthcare technology company headquartered in Bedford, Massachusetts with additional offices in New Jersey, Canada, and Sweden. Founded in 1956, the company pioneers medical imaging technologies and provides innovative diagnostics, targeted therapeutics, and artificial intelligence solutions for healthcare. Lantheus specializes in de... Read More
